Literature DB >> 16861565

Percutaneous MR-guided radiofrequency ablation of recurrent sacrococcygeal chordomas.

Volker Teichgräber1, Christophe Aubé, Diethard Schmidt, Ekkehard Jehle, Claudius König, Claus D Claussen, Philippe L Pereira.   

Abstract

OBJECTIVE: Radiofrequency ablation is emerging as a therapeutic technique for the treatment of an increasing variety of tumors. Exact visual guidance to the tumor and controlled delivery of energy is pivotal for ablation success.
CONCLUSION: Introducing MRI as a guidance technique ideally uses tumor-specific tissue characteristics, allows direct multiplanar reconstruction for precise needle positioning, and permits real-time monitoring and assessment of treatment-induced tissue signal changes to increase the safety of the procedure.

Entities:  

Mesh:

Year:  2006        PMID: 16861565     DOI: 10.2214/AJR.05.1529

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

Review 1.  Interventional articular and para-articular knee procedures.

Authors:  Radhesh K Lalam; Naomi Winn; Victor N Cassar-Pullicino
Journal:  Br J Radiol       Date:  2015-12-18       Impact factor: 3.039

2.  Radiofrequency ablation in gross total excision of cervical chordoma: ideas and technique.

Authors:  Hua Zhou; Xiaoxiong Yang; Liang Jiang; Feng Wei; Xiaoguang Liu; Zhongjun Liu
Journal:  Eur Spine J       Date:  2018-06-18       Impact factor: 3.134

Review 3.  Bone and soft tissue ablation.

Authors:  Ryan C B Foster; Joseph M Stavas
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 4.  Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.

Authors:  S Stacchiotti; A Gronchi; P Fossati; T Akiyama; C Alapetite; M Baumann; J Y Blay; S Bolle; S Boriani; P Bruzzi; R Capanna; A Caraceni; R Casadei; V Colia; J Debus; T Delaney; A Desai; P Dileo; S Dijkstra; F Doglietto; A Flanagan; S Froelich; P A Gardner; H Gelderblom; Z L Gokaslan; R Haas; C Heery; N Hindi; P Hohenberger; F Hornicek; R Imai; L Jeys; R L Jones; B Kasper; A Kawai; M Krengli; A Leithner; I Logowska; J Martin Broto; D Mazzatenta; C Morosi; P Nicolai; O J Norum; S Patel; N Penel; P Picci; S Pilotti; S Radaelli; F Ricchini; P Rutkowski; S Scheipl; C Sen; E Tamborini; K A Thornton; B Timmermann; V Torri; P U Tunn; M Uhl; Y Yamada; D C Weber; D Vanel; P P Varga; C L A Vleggeert-Lankamp; P G Casali; J Sommer
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

5.  The clinical outcomes for chordomas in the cranial base and spine: A single center experience.

Authors:  Yibiao Zhou; Bolin Hu; Zhiwei Wu; Hanxiong Cheng; Min Dai; Bin Zhang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.